101 |
Ofloxacin Tablets IP 200mg (-Not Available) |
|
|
10's |
-n/a- |
2027-08-21 |
0 |
0 |
102 |
Ofloxacin Tablets IP 400mg |
|
|
10's |
GT40399 |
2026-07-31 |
630 |
35 |
103 |
Piperacillin 4000mg and Tazobactum 500mg Injection IP |
|
|
Vial & wfi |
Z24-909 |
2026-10-31 |
106 |
122 |
104 |
Roxithromycin Oral Suspension 50 mg per 5ml (-Not Available) |
|
|
30 ml |
-n/a- |
2027-08-21 |
0 |
0 |
105 |
Roxithromycin Tablets IP 150 mg |
|
|
10's |
3506 |
2026-06-30 |
350 |
28 |
106 |
Roxithromycin Tablets IP 300 mg |
|
|
10's |
RNT3401 |
2025-12-31 |
210 |
50 |
107 |
Tinidazole Tablets IP 300 mg (-Not Available) |
|
|
10's |
-n/a- |
2027-08-21 |
0 |
0 |
108 |
Tinidazole Tablets IP 500 mg (-Not Available) |
|
|
10's |
-n/a- |
2027-08-21 |
0 |
0 |
109 |
Vancomycin Hydrochloride for Intravenous Infusion IP 500 mg |
|
|
Vial & wfi |
I4BVA011A |
2026-01-31 |
489 |
135 |
110 |
Adapalene Gel 0.1%w/w |
|
|
15 gm tubes |
4U07 |
2026-08-31 |
843 |
29 |
112 |
Beclomethasone Dipropionate 0.025%w/w, Clotrimazole 1%w/w and Gentamicin Sulphate 0.1%w/w Cream |
|
|
15 g tubes |
1315CG |
2027-04-30 |
483 |
20 |
113 |
Beclomethasone 0.025%w/w and Neomycin 0.5%w/w Cream |
|
|
15g tube |
5N18 |
2027-01-31 |
788 |
11 |
115 |
Calamine Lotion IP |
|
|
100 ml |
CAL1236 |
2026-10-31 |
217 |
28 |
117 |
Chlorhexidine Mouthwash IP 0.2 % w/v |
|
|
100 ml |
4AUL006 |
2026-08-31 |
1997 |
23 |
118 |
Clobetasol Propionate Cream IP 0.05 % w/w |
|
|
15 gm Tube |
5P03 |
2027-03-31 |
936 |
15 |
119 |
Fluconazole Tablets 150 mg Film Coated Capsule (-Not Available) |
|
|
10's |
-n/a- |
2027-08-21 |
0 |
0 |
120 |
Fusidic Acid Cream IP 2% w/w (-Not Available) |
|
|
5 gm Tube |
-n/a- |
2027-08-21 |
0 |
0 |
122 |
Ketoconazole Lotion 2% w/v (-Not Available) |
|
|
100 ML bottle |
-n/a- |
2027-08-21 |
0 |
0 |
123 |
Lignocaine 2% w/w Ointment (-Not Available) |
|
|
30 g tube |
-n/a- |
2027-08-21 |
0 |
0 |
124 |
Povidone Iodine Ointment 5% w/w (-Not Available) |
|
|
250 gm tubes/Jar |
-n/a- |
2027-08-21 |
0 |
0 |
125 |
Povidone Iodine Ointment 5% w/w |
|
|
15 gm tubes |
2501122 |
2026-12-31 |
928 |
15.4 |
126 |
Povidone-Iodine Solution IP 10 % w/v (-Not Available) |
|
|
500 ml |
-n/a- |
2027-08-21 |
0 |
0 |
127 |
Povidone-Iodine Solution IP 5 % w/v |
|
|
100 ml |
BP40003 |
2025-12-31 |
1124 |
21 |
128 |
Povidone Iodine 5% Solution 500 ML (-Not Available) |
|
|
500 ml |
-n/a- |
2027-08-21 |
0 |
0 |
129 |
Povidone Iodine Solution 7.5% w/v (-Not Available) |
|
|
500 ml |
-n/a- |
2027-08-21 |
0 |
0 |
130 |
Chlorhexidine Gluconate and Cetrimide Solution (1.5% w/v and 3% w/v) (-Not Available) |
|
|
100 ML bottle |
-n/a- |
2027-08-21 |
0 |
0 |
131 |
Silver Sulphadiazine 1% w/w, Chlorhexidine Gluconate 0.2% w/w, Allantoin 0.1% w/w, Aloe vera 15% w/w Cream |
|
|
20 GM |
BP50017 |
2027-04-30 |
642 |
30 |
132 |
Silver Sulphadiazine 1% w/w, Chlorhexidine Gluconate 0.2% w/w, Allantoin 0.1% w/w, Aloe vera 15% w/w Cream (-Not Available) |
|
|
500 gm |
-n/a- |
2027-08-21 |
0 |
0 |
133 |
Glibenclamide Tablets IP 2.5 mg |
|
|
10's |
GBAT1103 |
2025-09-30 |
1519 |
3 |
134 |
Glibenclamide Tablets IP 5 mg |
|
|
10's |
OBZO09 |
2025-11-30 |
290 |
5.5 |
135 |
Gliclazide Tablets IP 40 mg |
|
|
10's |
MT250387 |
2026-12-31 |
1200 |
15.4 |
136 |
Gliclazide Tablets IP 80 mg |
|
|
10's |
Z24-348 |
2026-04-30 |
610 |
24 |
137 |
Glimepiride Tablets IP 1mg |
|
|
10's |
GOF6005 |
2026-10-31 |
3310 |
4.4 |
138 |
Glimepiride Tablets IP 2mg |
|
|
10's |
PRT2501-64 |
2026-12-31 |
5150 |
5.5 |
139 |
Metformin 500mg SR,Pioglitazone 15mg,Glimeperide 1mg Tablet (-Not Available) |
|
|
10's |
-n/a- |
2027-08-21 |
0 |
0 |
140 |
Metformin 500mg SR, Pioglitazone 15mg, Glimeperide 2mg Tablet (-Not Available) |
|
|
10's |
-n/a- |
2027-08-21 |
0 |
0 |
141 |
Glipizide Tablet IP 5 mg |
|
|
10's |
Z24-346 |
2026-04-30 |
680 |
5 |
142 |
Soluble Insulin Injection IP 40 IU per ml (R-DNA Origin) |
|
|
10 ML VIAL |
TB9230624 |
2026-05-31 |
15680 |
71 |
143 |
Insulin Injection IP 40 IU per ml (Insulin Human Soluble 30% and Isophane 70%) |
|
|
10 ML VIAL |
V25ITF4002 |
2028-03-31 |
4905 |
90 |
144 |
Metformin Hydrochloride Sustained Release Tablets IP 1000 mg |
|
|
10's |
240800 |
2027-05-31 |
7254 |
13.2 |
145 |
Metformin Hydrochloride Tablets IP 500mg |
|
|
10's |
CT24251022 |
2026-08-31 |
10080 |
6.6 |
146 |
Pioglitazone 15 mg Tablets IP (-Not Available) |
|
|
10's |
-n/a- |
2027-08-21 |
0 |
0 |
147 |
Pioglitazone Tablets IP 30mg |
|
|
10's |
MT241709 |
2026-03-31 |
1020 |
13.2 |
150 |
Pioglitazone 15mg and Metformin 500mg Sustained Release Tablets |
|
|
10's |
A08072406 |
2026-04-30 |
1160 |
27 |
152 |
Bleomycin Injection IP 15 IU (-Not Available) |
|
|
Vial |
-n/a- |
2027-08-21 |
0 |
0 |
153 |
Cisplatin Injection IP 10 mg per10ml |
|
|
Vial |
Z23-1208 |
2025-09-30 |
188 |
35 |
154 |
Cisplatin Injection 50mg per 50ml (-Not Available) |
|
|
Vial |
-n/a- |
2027-08-21 |
0 |
0 |
155 |
Doxorubicin 10 mg Inj. (-Not Available) |
|
|
Vial |
-n/a- |
2027-08-21 |
0 |
0 |
156 |
Doxorubicin Injection IP 50mg (2mg per ml) (-Not Available) |
|
|
Vial |
-n/a- |
2027-08-21 |
0 |
0 |
158 |
Etoposide Injection IP 100 mg per 5 ml (-Not Available) |
|
|
Vial |
-n/a- |
2027-08-21 |
0 |
0 |
159 |
Gemcitabine Injection IP 1000mg (-Not Available) |
|
|
Vial |
-n/a- |
2027-08-21 |
0 |
0 |
160 |
Gemcitabine Injection IP 200mg (-Not Available) |
|
|
Vial |
-n/a- |
2027-08-21 |
0 |
0 |
162 |
Raloxifene Tablets strength 60 mg (-Not Available) |
|
|
10x10 |
-n/a- |
2027-08-21 |
0 |
0 |
163 |
Tamoxifen Citrate Tablets IP 10 mg |
|
|
10's |
TXT1105 |
2026-01-31 |
60 |
11 |
164 |
Tamoxifen Citrate Tablets IP 20 mg |
|
|
10's |
GST24138 |
2027-08-31 |
260 |
16 |
165 |
Ciprofloxacin Injection IP 200mg |
|
|
100 ml |
Z23-1219 |
2025-10-31 |
125 |
12 |
169 |
Levofloxacin 500 mg Infusion (-Not Available) |
|
|
100 ml |
-n/a- |
2027-08-21 |
0 |
0 |
170 |
Mannitol Injection IP 20% w/v (-Not Available) |
|
|
100 ml |
-n/a- |
2027-08-21 |
0 |
0 |
171 |
Mannitol Intravenous Infusion IP 20% w/v (-Not Available) |
|
|
350 ml |
-n/a- |
2027-08-21 |
0 |
0 |
172 |
Metronidazole Infusion IP 500 mg |
|
|
100 ml |
2308A0183 |
2027-05-31 |
1837 |
8 |
174 |
Plasma Volume Expander (Gelatin Base) (-Not Available) |
|
|
500 ml |
-n/a- |
2027-08-21 |
0 |
0 |
175 |
Ringer Lactate (RL) (-Not Available) |
|
|
500 ml |
-n/a- |
2027-08-21 |
0 |
0 |
176 |
Sterile Water for Injection (-Not Available) |
|
|
5 ml Amp. |
-n/a- |
2027-08-21 |
0 |
0 |
177 |
Albendazole Oral Suspension IP 200 mg per 5ml |
|
|
10 ml |
ABOS-1041 |
2027-01-31 |
18 |
8 |
178 |
Albendazole 400mg and Ivermectin 6mg Tablets (-Not Available) |
|
|
1's |
-n/a- |
2027-08-21 |
0 |
0 |
179 |
Albendazole Tablets IP 400MG (-Not Available) |
|
|
10's |
-n/a- |
2027-08-21 |
0 |
0 |
180 |
Bisacodyl Tablets IP 5mg |
|
|
10's |
BAST-1052 |
2026-11-30 |
1330 |
6 |
181 |
Tricholine Citrate 275mg and Cyproheptadine Hydrochloride 2mg Syrup per 5ml |
|
|
200 ml |
2504107 |
2027-03-31 |
811 |
38 |
183 |
Dicyclomine Tablets IP 10mg (-Not Available) |
|
|
10's |
-n/a- |
2027-08-21 |
0 |
0 |
184 |
Paracetamol 325mg and Dicyclomine Hydrochloride 20mg Tablets (-Not Available) |
|
|
10's |
-n/a- |
2027-08-21 |
0 |
0 |
185 |
Diethylcarbamazine citrate 100mg film coated Tablets (-Not Available) |
|
|
10's |
-n/a- |
2027-08-21 |
0 |
0 |
186 |
Domperidone Tablets IP 10 mg |
|
|
10's |
DO1TF002 |
2026-12-31 |
10 |
4.4 |
187 |
Domperidone Suspension IP 5mg per 5ml |
|
|
30 ml |
B3L0541A |
2025-11-30 |
1499 |
13 |
188 |
Dried Aluminium Hydroxide 250mg, Magnesium Hydroxide 250mg and Activated Dimethicone 50mg Tablets |
|
|
10's |
ACT1201 |
2026-12-31 |
400 |
6 |
191 |
Famotidine Tablets IP 20 mg (-Not Available) |
|
|
14's |
-n/a- |
2027-08-21 |
0 |
0 |
192 |
Famotidine Tablets IP 40 mg (-Not Available) |
|
|
14's |
-n/a- |
2027-08-21 |
0 |
0 |
193 |
Furazolidone Tablets IP 100 mg |
|
|
10's |
FUT2306 |
2025-09-30 |
240 |
1 |
194 |
Hyoscine Butylbromide Tablets IP 10 mg |
|
|
10's |
T3588 |
2026-08-31 |
530 |
17.6 |
195 |
Ispaghula Husk IP 200gm (-Not Available) |
|
|
200 gm tetrapack |
-n/a- |
2027-08-21 |
0 |
0 |
196 |
Lactic Acid Bacillus Tablets 60 Million spores |
|
|
10's |
TLAB-025 |
2027-04-30 |
10860 |
7.7 |
197 |
Lactulose Solution IP 10g per 15ml (-Not Available) |
|
|
100 ml |
-n/a- |
2027-08-21 |
0 |
0 |
198 |
Dried Aluminium Hydroxide 250mg, Magnesium Hydroxide 250mg and Activated Dimethicone 50mg per 5ml Suspension (-Not Available) |
|
|
170 ml |
-n/a- |
2027-08-21 |
0 |
0 |
199 |
Metoclopramide Tablets IP 10 mg |
|
|
10's |
DTF-026 |
2026-05-31 |
580 |
8 |
200 |
Metoclopramide Injection IP 5mg per ml |
|
|
2ml Ampoule |
PMCIL-001 |
2026-12-31 |
6570 |
3 |
201 |
Metronidazole Tablets IP 200mg |
|
|
10's |
MLFT1201 |
2026-05-31 |
1240 |
4 |
202 |
Metronidazole Tablets IP 400mg |
|
|
10's |
GT40823 |
2026-12-31 |
1470 |
7 |
203 |
Misoprostol Tablets IP 200 mcg |
|
|
4's |
DDAE04 |
2026-05-31 |
1980 |
20 |
204 |
Norfloxacin 100mg+ Metronidazole 100mg/5 ml Syrup (-Not Available) |
|
|
30 ml bottle |
-n/a- |
2027-08-21 |
0 |
0 |
206 |
Omeprazole 20mg and Domperidone 10mg Capsules IP |
|
|
10's |
OPDC-1019 |
2027-03-31 |
6030 |
11 |
207 |
Omeprazole Gastro-resistant Capsules IP 20 mg |
|
|
10's |
Z24-713 |
2026-08-31 |
2710 |
9.9 |
208 |
Ondansetron Injection IP 2mg per ml |
|
|
2 ml |
ONG-68 |
2026-12-31 |
14 |
4.4 |
209 |
Ondansetron Tablets IP 4 mg |
|
|
10's |
AUE07BDA |
2027-03-31 |
2570 |
6.6 |
210 |
Ornidazole Tablets IP 500mg |
|
|
10's |
OR1TE006 |
2026-06-30 |
870 |
25 |
212 |
Pantoprazole Gastro Resistant Tablets IP 40 mg |
|
|
10's |
C21P885009 |
2028-02-29 |
13190 |
12.1 |
213 |
Pantoprazole Injection 40mg |
|
|
Vial |
PGY24022 |
2026-04-30 |
16664 |
23.1 |
214 |
Rabeprazole 20mg (Enteric Coated) and Domperidone 30mg (Sustained Release) Capsules (-Not Available) |
|
|
10's |
-n/a- |
2027-08-21 |
0 |
0 |
215 |
Rabeprazole Gastro Resistant Tablets IP 20 mg |
|
|
10's |
TRA503 |
2026-12-31 |
1320 |
8.8 |
216 |
Ranitidine Injection IP 25 mg per ml (-Not Available) |
|
|
2 ml |
-n/a- |
2027-08-21 |
0 |
0 |
217 |
Ranitidine Tablets IP 150 mg |
|
|
10's |
RDHT-1058 |
2028-01-31 |
3490 |
6 |
218 |
Ranitidine Tablets IP 300 mg (-Not Available) |
|
|
10's |
-n/a- |
2027-08-21 |
0 |
0 |